Boris Johnson pledges to offer all adults a coronavirus vaccine by July 31
Boris Johnson has pledged to offer all adults in the UK a coronavirus vaccine by the end of July as he prepares to set out his road map to relax lockdown restrictions in England.
The Prime Minister said the accelerated rollout of jabs would enable the easing of some of the stringent measures – but insisted that the unlocking would be “cautious and phased”.
Mr Johnson has spent the past week considering data on deaths, cases, hospital admissions and the effect of the vaccine rollout, and will unveil his blueprint to Parliament on Monday.
The road map is expected to include target dates for the relaxation of restrictions, but a Government source stressed that they would be guided by the data at each stage.
It will include an expedited target to vaccinate all adults aged over 50 – as well as those with underlying health conditions which put them at higher risk – by April 15.
By July 31, the Government hopes to have offered all adults in the UK a jab – though the order of priority for those under 50 has yet to be outlined by the Joint Committee on Vaccination and Immunisation (JCVI).
Ministers had set a target to offer vaccines to all adults by September, with an aim to reach all those aged 50 and over in the first nine JCVI priority groups by May.
The new targets will be seen as a sign of increasing confidence within the Government that the vaccine supply will remain steady over the coming months.
An ambition to offer jabs to all those in the top four priority groups – adults aged 70 and over, frontline health and social care workers and the most clinically vulnerable – was met by February 15.
Mr Johnson said there would be “no let up” in the vaccine rollout, saying he wanted to see it go “further and faster in the coming weeks”.
“We will now aim to offer a jab to every adult by the end of July, helping us protect the most vulnerable sooner, and take further steps to ease some of the restrictions in place.
“But there should be no doubt – the route out of lockdown will be cautious and phased, as we all continue to protect ourselves and those around us.”
The PM will chair a meeting of senior ministers on Sunday, known as the “Covid S” committee, to finalise his road map before it is signed off by the Cabinet on Monday.
He will then unveil the plans to MPs in the Commons later that afternoon and is expected to lead a Downing Street press conference on Monday evening.
In other developments:
– A further 445 people died within 28 days of testing positive for Covid-19 as of Saturday, while there were another 10,406 lab-confirmed cases of coronavirus in the UK.
– More than 17.2 million people have now received their first dose of a coronavirus vaccine, while more than 600,000 people have received their second, the Government said.
– A 16-year-old with no known underlying health conditions was among the latest reported deaths of people who have tested positive for coronavirus in England.
– NHS England said that more than two thirds of people aged between 65 and 69 have had their first dose of a coronavirus vaccine just a week after invitations went out.
– Health Secretary Matt Hancock announced that care home residents will be allowed to hold hands with a regular indoor visitor from March 8.
Labour welcomed the accelerated vaccine target, but called on the Government to “urgently” set out how they will prioritise those aged under 50.
Shadow health secretary Jonathan Ashworth said: “It’s perfectly reasonable for teachers, police officers and other key workers who haven’t been able to stay at home in the lockdown to ask when their turn will be.
“If Government aren’t going to prioritise by occupation in the next phase they need to set out why.
“Vaccination must go hand-in-hand with measures to break transmission chains. That means paying people decent financial support to isolate, updating face coverings guidance and insisting in ventilation standards to ensure all workplaces are Covid secure.”
Downing Street said the JCVI would publish its priority list for the second phase of the vaccine programme in due course.